Literature DB >> 8648660

Attitudes of African Americans regarding screening for prostate cancer.

S B Robinson1, M Ashley, M A Haynes.   

Abstract

The purpose of this study was to identify attitudes associated with the willingness of African Americans to participate in prostate cancer screening. Subjects > or = 40 years were recruited from South Central Los Angeles. Fifty-six respondents were divided into low or middle socioeconomic groups based on education and occupation. Focus group discussions were conducted to assess knowledge, attitudes, and beliefs about prostate cancer screening and treatment, willingness to participate in screening, incentives and barriers toward participating in screening, and source of medical care. The middle socioeconomic respondents expressed a greater willingness to participate in prostate screening. This difference was attributed to their greater knowledge about the disease and screening procedures, enhanced access to health promotion activities, being less fearful of discovering abnormal results, exposure to more aggressive behavior on the part of the provider with respect to screening, and receiving medical care in an environment that is more respectful toward the consumer. Efforts to increase minority participation in prostate cancer screening or prevention studies must take these findings into consideration.

Entities:  

Mesh:

Year:  1996        PMID: 8648660      PMCID: PMC2608049     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  18 in total

1.  Case-control study of screening for prostatic cancer by digital rectal examinations.

Authors:  G D Friedman; R A Hiatt; C P Quesenberry; J V Selby
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

2.  Why do some women get regular mammograms?

Authors:  B K Rimer; B Trock; P F Engstrom; C Lerman; E King
Journal:  Am J Prev Med       Date:  1991 Mar-Apr       Impact factor: 5.043

3.  Questioning the value of screening for prostate cancer in asymptomatic men.

Authors:  G W Chodak
Journal:  Urology       Date:  1993-08       Impact factor: 2.649

Review 4.  Digital rectal examination in the early detection of prostate cancer.

Authors:  G S Gerber; G W Chodak
Journal:  Urol Clin North Am       Date:  1990-11       Impact factor: 2.241

5.  Assessment of screening for prostate cancer using the digital rectal examination.

Authors:  G W Chodak; P Keller; H W Schoenberg
Journal:  J Urol       Date:  1989-05       Impact factor: 7.450

6.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

Review 7.  The status of prostate cancer early detection.

Authors:  C Mettlin
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

8.  Prostate cancer screening: what we know and what we need to know.

Authors:  B S Kramer; M L Brown; P C Prorok; A L Potosky; J K Gohagan
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

9.  The role of focus groups in health education for cervical cancer among minority women.

Authors:  M Dignan; R Michielutte; P Sharp; J Bahnson; L Young; P Beal
Journal:  J Community Health       Date:  1990-12

10.  Effects of age, education, and physician advice on utilization of screening mammography.

Authors:  P P Coll; P J O'Connor; B F Crabtree; R W Besdine
Journal:  J Am Geriatr Soc       Date:  1989-10       Impact factor: 5.562

View more
  19 in total

1.  Knowledge, attitudes, and screening practices among older men regarding prostate cancer.

Authors:  C B Steele; D S Miller; C Maylahn; R J Uhler; C T Baker
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  A population-based survey of prostate cancer testing in New Mexico.

Authors:  R M Hoffman; F D Gilliland
Journal:  J Community Health       Date:  1999-12

3.  Prostate cancer screening and detection in inner-city and underserved men.

Authors:  Satoshi Anai; John Pendleton; Peter Wludyka; Christopher Williams; Leah Nelms; Curtis Pettaway; Charles J Rosser
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

4.  The importance of screening African Americans for prostate cancer.

Authors:  A Farkas
Journal:  J Natl Med Assoc       Date:  1997-12       Impact factor: 1.798

5.  Barriers to planning and conducting a screening: prostate cancer.

Authors:  Graham J McDougall; Mary Louise Adams; Wayne F Voelmeck
Journal:  Geriatr Nurs       Date:  2004 Nov-Dec       Impact factor: 2.361

6.  Differences between African American and Caucasian men participating in a community-based prostate cancer screening program.

Authors:  K R Barber; R Shaw; M Folts; D K Taylor; A Ryan; M Hughes; V Scott; R R Abbott
Journal:  J Community Health       Date:  1998-12

7.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Authors:  Evelyn C Y Chan; Sally W Vernon; Frederick T O'Donnell; Chul Ahn; Anthony Greisinger; Donnie W Aga
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

8.  Prostate cancer knowledge and screening attitudes of inner-city men.

Authors:  John Pendleton; Christopher Hopkins; Satoshi Anai; Kogenta Nakamura; Myron Chang; Anthony Grissett; Charles J Rosser
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

9.  Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries.

Authors:  Robert J Richards; Dean M Reker
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

10.  Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension.

Authors:  Crystal A Gadegbeku; Phyllis Kreger Stillman; Mark D Huffman; James S Jackson; John W Kusek; Kenneth A Jamerson
Journal:  Contemp Clin Trials       Date:  2008-06-27       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.